Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2025-12-25 @ 2:16 PM
Study NCT ID:
NCT00129766
Status:
COMPLETED
Last Update Posted:
2013-08-28
First Post:
2005-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-11
Start Date Type:
None
Primary Completion Date:
2006-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-10
First Submit QC Date:
None
Study First Post Date:
2005-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-06-21
Results First Submit QC Date:
None
Results First Post Date:
2013-08-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-21
Last Update Post Date:
2013-08-28
Last Update Post Date Type:
ESTIMATED